NCT03129529

Brief Summary

The main purpose of this study is to compare treatment efficacy of focused and radial extracorporeal shock waves on spasticity in chronic stroke patient

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 20, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 26, 2017

Completed
Last Updated

April 26, 2017

Status Verified

April 1, 2017

Enrollment Period

2 months

First QC Date

April 20, 2017

Last Update Submit

April 25, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline of spasticity on 1st, 4th, 8th weeks after treatment.

    Using the modyfied Ashworth Scale to measure the spasticity before treatment and multiple time frame after treatment.

    1, 4, 8 week

Secondary Outcomes (4)

  • Change from baseline of range of motion on 1st, 4th, 8th weeks after treatment.

    1, 4, 8 week

  • Change from baseline of modified Tardieu scale on 1st, 4th, 8th weeks after treatment.

    1, 4, 8 week

  • Change from baseline of foot contact area on 1st, 4th, 8th weeks after treatment.

    1, 4, 8 week

  • Change from baseline of gait speed on 8th weeks after treatment.

    8 week

Study Arms (2)

focused shock wave

EXPERIMENTAL

Treatment was administered directly to the middle of muscle bellies of the spastic triceps surae muscle in three sessions, with one week interval. During each session, 3000 pulses (1500 shots in the gastrocnemius and 1500 shots in the soleus muscle) were delivered at 5 Hz. The intensities of FSWT were 0.10 mJ/mm2.

Device: Focused shock wave

radial shock wave

EXPERIMENTAL

Treatment was administered directly to the middle of muscle bellies of the spastic triceps surae muscle in three sessions, with one week interval. During each session, 3000 pulses (1500 shots in the gastrocnemius and 1500 shots in the soleus muscle) were delivered at 5 Hz.The intensities of RSWT were 2.0 bar.

Device: Radial shock wave

Interventions

The outcome evaluation include ankle range of motion (ROM), modified Ashworth scale (MAS),modified Tardieu scale (MTS), baropodometric measurement, and gait speed.

focused shock wave

The outcome evaluation include ankle range of motion (ROM), modified Ashworth scale (MAS),modified Tardieu scale (MTS), baropodometric measurement, and gait speed.

radial shock wave

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged greater than 18 years old;
  • at least 6 months since onset of last stroke;
  • triceps surae muscle tone graded at least 1+ on the Modified Ashworth Scale (MAS) score;
  • ability to walk alone with/without orthosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mackay Memorial Hospital

Taipei, 104, Taiwan

Location

MeSH Terms

Conditions

Muscle Spasticity

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PHD

Study Record Dates

First Submitted

April 20, 2017

First Posted

April 26, 2017

Study Start

January 1, 2016

Primary Completion

March 1, 2016

Study Completion

January 1, 2017

Last Updated

April 26, 2017

Record last verified: 2017-04

Locations